Through a battery of behavioral tests assessing cognition and emotion, we found that activation of integrin αVβ5 by increased endogenous irisin could attenuate recognition memory deficits, short-term memory decline, hypokinetic behavior, and anxiety- and depression-like behaviors caused by CCH. Here, FNDC5 is linked to depressive disorder.